1) Traditionally used for the symptomatic relief of catarrh and head colds.
Methenamine Tablets is indicated in the prophylaxis of uncomplicated lower urinary tract infections: 1. As long-term prophylactic therapy after initial treatment with appropriate chemotherapeutic agent of recurrent urinary infections. 2. As long-term therapy in the prevention of recurrent cystitis. 3. To provide prophylaxis in patients with indwelling catheters, urine collector etc. and to reduce the incidence of catheter blockage. 4. To provide prophylaxis against the introduction of infection into urinary tract during instrumental procedures. 5. Asymptomatic bacteriuria.
HBVAXPRO is indicated for active immunisation against hepatitis B virus infection caused by all known subtypes in individuals 16 years of age or more considered at risk of exposure to hepatitis B virus. The specific at risk categories to be immunised are to be determined on the basis of the official recommendations. It can be expected that hepatitis D will also be prevented by immunisation with HBVAXPRO as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection.
Active immunisation against influenza in the elderly (65 years of age and over), especially for those with an increased risk of associated complications. The use of Fluad should be based on official recommendations.
HBVAXPRO is indicated for the active immunisation against hepatitis B virus infection caused by all known subtypes in predialysis and dialysis adult patients. It can be expected that hepatitis D will also be prevented by immunisation with HBVAXPRO as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection.